Author: News Room

Dublin, March 30, 2026 (GLOBE NEWSWIRE) — The “Bile Duct Cancer Market Report 2026” has been added to ResearchAndMarkets.com’s offering. The bile duct cancer market is witnessing robust growth, expanding from $2.59 billion in 2025 to an anticipated $2.82 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. This growth is fueled by advancements in early diagnostics, a rising incidence of liver and bile duct disorders, and the expansion of oncology treatment centers. Additionally, the increasing use of chemotherapy regimens and growing awareness of rare cancers contribute to market momentum. Looking ahead, the bile duct cancer market…

WASHINGTON, March 30, 2026 (GLOBE NEWSWIRE) — Pallas Advisors is pleased to announce that General (Ret.) Kenneth F. “Frank” McKenzie, Jr. has joined the Pallas Speakers Bureau, a platform connecting global audiences with top-tier national security experts. Following his retirement from the U.S. Marine Corps in 2022, General McKenzie has served as Executive Director of the Global and National Security Institute and Cyber Florida at the University of South Florida. He has also been named the 21st President of The Citadel, beginning in July 2026. General McKenzie brings decades of experience leading large, complex organizations in high-pressure, rapidly evolving environments.…

VICTORIA, Seychelles, March 30, 2026 (GLOBE NEWSWIRE) — MEXC, the world’s fastest-growing digital asset exchange and a pioneer of true zero-fee trading, has listed the twelfth batch of Ondo tokenized stock trading pairs on its spot market, as part of its ongoing collaboration with Ondo Finance. The batch comprises 20 new pairs, all available to trade with zero fees for the first 30 days. The new pairs were introduced across two listing dates. The first ten went live on March 27, 2026, and the remaining ten on March 30, 2026. The batch includes AXPON/USDT, SBUXON/USDT, AMGNON/USDT, NEMON/USDT, and VRTXON/USDT, among…

Dublin, March 30, 2026 (GLOBE NEWSWIRE) — The “Pancreatic Adenocarcinoma Treatment Market Report 2026” has been added to ResearchAndMarkets.com’s offering. The pancreatic adenocarcinoma treatment market is witnessing remarkable growth, projected to expand from $2.41 billion in 2025 to $2.73 billion in 2026 at a 13.3% CAGR. This escalation is rooted in limited treatment alternatives, reliance on traditional chemotherapy, low early-stage diagnosis, and hospital-centric treatment approaches. Looking ahead, the market is expected to soar to $4.45 billion by 2030, driven by personalized targeted therapies, the rising use of monoclonal antibodies and immunotherapies, digital health solutions, and combination therapy protocols. Increasing incidences…

Dublin, March 30, 2026 (GLOBE NEWSWIRE) — The “Paraganglioma Market Report 2026” has been added to ResearchAndMarkets.com’s offering.The paraganglioma market is on an upward trajectory, with projections indicating a growth from $3.02 billion in 2025 to $3.76 billion by 2030, achieving a CAGR of 4.4%. This growth is propelled by advancements in biologic and immunotherapy drugs, a surge in autoimmune and infectious disorders, and innovative integrations like AI in diagnostics, teleophthalmology, and digital monitoring. These trends are reshaping the landscape of the paraganglioma market, enhancing diagnostic and treatment pathways. Investment influx in oncology research is a key driver, addressing the…

Introduction LAS VEGAS, March 30, 2026 (GLOBE NEWSWIRE) — EverForward Trading has announced a significant achievement as Brian Ferdinand, Portfolio Manager and Trader at the firm, has been selected to join the prestigious Forbes Finance Council. This invitation-only community, curated by Forbes, brings together some of the most accomplished leaders in the global financial industry. Ferdinand’s inclusion marks an important milestone not only in his professional journey but also in the continued growth and recognition of EverForward Trading. About the Forbes Finance Council The Forbes Finance Council is widely regarded as a leading network of senior-level finance executives, investors, and industry…

Dublin, March 30, 2026 (GLOBE NEWSWIRE) — The “Neuroblastoma Market Report 2026” has been added to ResearchAndMarkets.com’s offering.The neuroblastoma market has witnessed significant growth, projected to expand from $3.14 billion in 2025 to $3.32 billion in 2026, with a CAGR of 5.8%. Factors driving this growth include an increase in pediatric neuroblastoma cases and advancements in treatment modalities, including chemotherapy and immunotherapy vaccines. Clinical diagnostic capabilities have also improved, leading to better early detection and heightened awareness of childhood cancer symptoms. Looking ahead, the neuroblastoma market is set to continue its upward trajectory, reaching $4.12 billion by 2030 at a…

Dublin, March 30, 2026 (GLOBE NEWSWIRE) — The “Non-Muscle Invasive Bladder Cancer Market Report 2026” has been added to ResearchAndMarkets.com’s offering. The non-muscle invasive bladder cancer (NMIBC) market size has experienced robust growth, increasing from $3.66 billion in 2025 to an anticipated $4.82 billion by 2030. This expansion is driven by factors such as a rise in early diagnosis, enhanced use of transurethral resection, and increased adoption of immunotherapy and chemotherapy. Improvements in hospital pharmacy infrastructure and the development of online and retail pharmacy channels have also contributed significantly. Personalized medicine is playing a crucial role in steering NMIBC market…

Dublin, March 30, 2026 (GLOBE NEWSWIRE) — The “Cancer Supportive Care Products Market Report 2026” has been added to ResearchAndMarkets.com’s offering. This report offers valuable insights into global market size, regional shares, competitive analysis, and emerging trends, delivering an in-depth perspective critical for thriving in the cancer supportive care products industry. The global cancer supportive care products market is steadily evolving, with an anticipated growth from $22.47 billion in 2025 to $23.54 billion in 2026 at a CAGR of 4.8%. Historical growth is driven by increasing global cancer prevalence, rising chemotherapy and radiation therapy applications, and a higher incidence of…

Dublin, March 30, 2026 (GLOBE NEWSWIRE) — The “Chemotherapy At Home Services Market Report 2026” has been added to ResearchAndMarkets.com’s offering. The report offers a comprehensive analysis, detailing industry size, trends, and opportunities. The report provides tactical insights into current and future scenarios, supporting stakeholder strategies for navigating the evolving landscape. The chemotherapy-at-home services market is experiencing rapid growth, with an anticipated increase from $1.94 billion in 2025 to $2.16 billion in 2026, reflecting a compound annual growth rate (CAGR) of 11.1%. This expansion is supported by the development of outpatient cancer treatment programs, heightened demand for patient-centric care, and…